棕榈酸通过Keap1棕榈酰化诱导视网膜微血管内皮细胞铁死亡影响糖尿病视网膜病变
研究在糖尿病大鼠和高糖处理的人视网膜微血管内皮细胞(HRMECs)中探索棕榈酸(PA)导致糖尿病视网膜病变(DR)中视网膜微血管内皮细胞损伤的新机制。结果显示PA通过促进Keap1棕榈酰化上调Keap1水平,抑制Nrf2/GPX4通路,从而增强HRMECs铁死亡并加重DR;si-Keap1可逆转上述改变并在体内减轻DR和铁死亡。
要点
- 糖尿病大鼠视网膜和高糖HRMECs中均观察到铁死亡,伴Keap1、ACSL4、MDA、ROS升高及GSH、Nrf2、GPX4降低。
- PA对HRMECs铁死亡的促进作用可被2-溴十六烷酸逆转、被Palmostatin B进一步增强。
- si-Keap1可逆转PA诱导的Keap1、ACSL4、MDA、ROS升高及Nrf2、GPX4、GSH降低,并在体内减轻DR和铁死亡。
核心结论
- 结果提示PA通过诱导Keap1棕榈酰化上调Keap1水平,抑制Nrf2/GPX4通路,从而增强HRMECs铁死亡并加重DR。
研究设计与样本
- 研究使用糖尿病大鼠和高糖处理的人视网膜微血管内皮细胞(HRMECs)进行体内和体外实验。
- 视网膜组织病理变化用苏木精-伊红染色评估,CD206和CD86表达用免疫组化染色和流式细胞术检测,细胞活力用Cell Counting Kit-8测定,蛋白水平用Western blot检测。
主要发现
- 糖尿病大鼠视网膜组织和高糖处理的HRMECs中诱导了铁死亡,表现为Keap1、ACSL4、MDA和ROS水平升高,而GSH、Nrf2和GPX4水平降低。
- PA对HRMECs铁死亡表现出类似的促进作用,该作用可被2-溴十六烷酸逆转,并被Palmostatin B进一步增强。
- HRMECs中Keap1的棕榈酰化修饰得到证实,si-Keap1逆转了PA诱导的Keap1、ACSL4、MDA和ROS升高以及Nrf2、GPX4和GSH降低。
- 体内实验进一步显示si-Keap1减轻DR并减少铁死亡。
关键数值与推荐
- 铁死亡验证指标:Keap1、ACSL4、MDA、ROS水平升高,GSH、Nrf2、GPX4水平降低。
- PA对HRMECs铁死亡的促进作用被2-溴十六烷酸逆转,被Palmostatin B进一步增强。
- si-Keap1可逆转PA诱导的Keap1、ACSL4、MDA和ROS升高及Nrf2、GPX4和GSH降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Retinal microvascular endothelial cells (RMECs) injury caused by sustained hyperglycemia was the initial factor in diabetic retinopathy (DR). Here, we explored a novel mechanism by which palmitic acid (PA) contributed to RMEC damage in DR. METHODS: Diabetic rats and high glucose (HG)-treated human RMECs (HRMECs) were used for the in vivo and in vitro experiments. The pathological changes of retinal tissues were evaluated by hematoxylin & eosin staining; mannose receptor (CD206) and B7-2 (CD86) expression were detected by immunohistochemical staining and flow cytometry; cell viability was measured using Cell Counting Kit-8; the protein levels were detected by Western blot. RESULTS: Ferroptosis was induced in the retinal tissues of diabetic rats and HG-treated HRMECs, which was verified by increased kelch-like ECH-associated protein 1 (Keap1), acyl-CoA synthetase long-chain family member 4 (ACSL4), malondialdehyde (MDA), and reactive oxygen species (ROS) levels, whereas glutathione (GSH), nuclear factor erythroid 2-related factor 2 (Nrf2), and glutathione peroxidase 4 (GPX4) levels were decreased. PA exhibited the similar promotion effect on ferroptosis in HRMECs, which was reversed by 2-bromohexadecanoic acid and further enhanced by Palmostatin B. The palmitoylation modification of Keap1 in HRMECs was confirmed, and si-Keap1 reversed the increased Keap1, ACSL4, MDA and ROS, decreased Nrf2, GPX4 and GSH induced by PA. The in vivo experiments further revealed that si-Keap1 alleviated DR and reduced ferroptosis. CONCLUSIONS: These results suggested that PA induced Keap1 palmitoylation to upregulate Keap1 levels to inhibit Nrf2/GPX4 pathway, thus enhancing ferroptosis in HRMECs and aggravating DR.
引用
- Mao Z, Yang W, Chao Y, et al. Palmitic Acid Induces Ferroptosis in Retinal Microvascular Endothelial Cells by Palmitoylation of Keap1 to Affect Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 41247128. doi:10.1167/iovs.66.14.41
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。